BELYSSE GROUP NV (BELYS.BR) Fundamental Analysis & Valuation

EBR:BELYS • BE0974314461

0.7 EUR
-0.01 (-1.41%)
Last: Mar 11, 2026, 12:23 PM

This BELYS.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

BELYS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Household Durables industry. BELYS may be in some trouble as it scores bad on both profitability and health. BELYS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. BELYS.BR Profitability Analysis

1.1 Basic Checks

  • In the past year BELYS has reported negative net income.
  • BELYS had a positive operating cash flow in the past year.
  • BELYS had negative earnings in 4 of the past 5 years.
  • BELYS had a positive operating cash flow in 4 of the past 5 years.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • BELYS's Return On Assets of -0.02% is on the low side compared to the rest of the industry. BELYS is outperformed by 62.50% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.07%, BELYS is doing worse than 65.63% of the companies in the same industry.
  • BELYS's Return On Invested Capital of 6.48% is fine compared to the rest of the industry. BELYS outperforms 65.63% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BELYS is below the industry average of 9.99%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • The Operating Margin of BELYS (6.94%) is better than 65.63% of its industry peers.
  • In the last couple of years the Operating Margin of BELYS has declined.
  • With an excellent Gross Margin value of 61.34%, BELYS belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.94%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. BELYS.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BELYS is destroying value.
  • The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, BELYS has an improved debt to assets ratio.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.26, we must say that BELYS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BELYS (0.26) is worse than 90.63% of its industry peers.
  • BELYS has a debt to FCF ratio of 4.98. This is a neutral value as BELYS would need 4.98 years to pay back of all of its debts.
  • BELYS's Debt to FCF ratio of 4.98 is fine compared to the rest of the industry. BELYS outperforms 68.75% of its industry peers.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that BELYS has dependencies on debt financing.
  • BELYS's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. BELYS is outperformed by 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Altman-Z 0.26
ROIC/WACC0.6
WACC10.82%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • BELYS has a Current Ratio of 1.63. This is a normal value and indicates that BELYS is financially healthy and should not expect problems in meeting its short term obligations.
  • BELYS has a Current ratio (1.63) which is in line with its industry peers.
  • BELYS has a Quick Ratio of 1.63. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.90, BELYS perfoms like the industry average, outperforming 53.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. BELYS.BR Growth Analysis

3.1 Past

  • The earnings per share for BELYS have decreased strongly by -100.85% in the last year.
  • Looking at the last year, BELYS shows a decrease in Revenue. The Revenue has decreased by -6.81% in the last year.
  • The Revenue has been growing slightly by 0.43% on average over the past years.
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.41% on average over the next years.
  • The Revenue is expected to grow by 0.36% on average over the next years.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. BELYS.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Forward Earnings ratio of 3.78, the valuation of BELYS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, BELYS is valued cheaply inside the industry as 96.88% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.39, BELYS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.78
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BELYS is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BELYS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.8
EV/EBITDA 3.78
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

0

5. BELYS.BR Dividend Analysis

5.1 Amount

  • BELYS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BELYS.BR Fundamentals: All Metrics, Ratios and Statistics

BELYSSE GROUP NV

EBR:BELYS (3/11/2026, 12:23:26 PM)

0.7

-0.01 (-1.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-20
Earnings (Next)03-13
Inst Owners12.64%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap25.16M
Revenue(TTM)270.29M
Net Income(TTM)-59.00K
Analysts84.44
Price Target1.63 (132.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.78
P/S 0.09
P/FCF 0.8
P/OCF 0.61
P/B 0.31
P/tB N/A
EV/EBITDA 3.78
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY26.49%
FCF(TTM)0.88
FCFY125.45%
OCF(TTM)1.15
OCFY163.75%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.91%
ROIC 6.48%
ROICexc 7.66%
ROICexgc 15.72%
OM 6.94%
PM (TTM) N/A
GM 61.34%
FCFM 11.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexgc growth 3Y21.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Debt/EBITDA 3.8
Cap/Depr 48.2%
Cap/Sales 3.56%
Interest Coverage 1.25
Cash Conversion 106.31%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.26
F-Score4
WACC10.82%
ROIC/WACC0.6
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.43%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y114.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


Can you provide the valuation status for BELYSSE GROUP NV?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


What is the financial health of BELYSSE GROUP NV (BELYS.BR) stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.